Skip to content

Dusting vs Fragmentation Laser Cystolithotripsy for Pediatric Bladder Stones

Dusting Versus Fragmentation With Holmium:YAG Laser During Transurethral Cystolithotripsy in Pediatric Bladder Stones: A Prospective Randomized Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07623980
Acronym
DUST-FRAG-PED
Enrollment
110
Registered
2026-06-03
Start date
2026-05-06
Completion date
2027-05-01
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Calculi, Pediatric Bladder Stones, Pediatric Urolithiasis

Keywords

Transurethral cystolithotripsy, Dusting, Holmium:YAG laser, Fragmentation, Bladder stone surgery

Brief summary

Bladder stones are a clinically relevant pediatric urological condition that may require endoscopic treatment. Transurethral Holmium:YAG laser cystolithotripsy is a minimally invasive option for selected children with bladder stones. This prospective randomized trial will compare two Holmium:YAG laser strategies during transurethral cystolithotripsy in children with a single bladder stone less than 3 cm: dusting and fragmentation. Children will be randomized to undergo laser dusting or laser fragmentation during transurethral cystolithotripsy. The primary outcome is total operative time. Secondary outcomes include laser time, need for active fragment extraction, endoscopic stone-free status at the end of the procedure, ultrasound-assessed stone-free status during follow-up, intraoperative complications, postoperative urinary symptoms, urinary tract infection, need for postoperative catheterization, and hospital stay.

Detailed description

This is a prospective randomized controlled trial conducted at the Department of Urology, Faculty of Medicine, Beni-Suef University Hospital. The study will include children with radiologically confirmed single bladder stones less than 3 cm who are planned for transurethral Holmium:YAG laser cystolithotripsy and are suitable for transurethral endoscopic management under general anesthesia. Written informed consent will be obtained from parents or legal guardians before enrollment. Eligible children will be randomized in a 1:1 ratio into two groups. Participants in the dusting group will undergo transurethral Holmium:YAG laser cystolithotripsy using low pulse energy and higher pulse frequency settings, with the aim of reducing the stone into fine particulate debris and tiny fragments with minimal need for active extraction. Participants in the fragmentation group will undergo transurethral Holmium:YAG laser cystolithotripsy using higher pulse energy and lower pulse frequency settings, with the aim of producing visible extractable fragments that can be actively removed when needed. All procedures will be performed under general anesthesia in the lithotomy position using a pediatric semi-rigid ureteroscope. A Holmium:YAG laser will be used in both groups. The planned settings are 0.5-0.8 J and 10-15 Hz in the dusting group, and 1.0 J and 6-10 Hz in the fragmentation group. A 550-micron end-firing laser fiber will be preferred when compatible with the available endoscope. The primary outcome is total operative time, defined as the time in minutes from insertion of the endoscope into the urethra until completion of stone clearance and termination of the procedure, including fragment retrieval when required. Secondary outcomes include laser time, need for active fragment extraction, endoscopic stone-free status at the end of the procedure, ultrasound-assessed stone-free status at follow-up, intraoperative mucosal injury or bleeding, need for postoperative catheterization, postoperative hematuria, dysuria, urinary tract infection, and hospital stay. Follow-up will be scheduled at 1 week, 1 month, and 3 months with clinical assessment and ultrasonography.

Interventions

PROCEDUREDusting Holmium:YAG Laser Cystolithotripsy

Transurethral Holmium:YAG laser cystolithotripsy using a dusting strategy with planned laser settings of 0.5-0.8 J and 10-15 Hz, aiming to reduce the bladder stone into fine particulate debris and tiny fragments with minimal need for active fragment extraction.

PROCEDUREFragmentation Holmium:YAG Laser Cystolithotripsy

Transurethral Holmium:YAG laser cystolithotripsy using a fragmentation strategy with planned laser settings of 1.0 J and 6-10 Hz, aiming to produce visible extractable stone fragments of approximately 2-5 mm, with active fragment removal when needed.

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The operating surgeon cannot be blinded because of the nature of the laser technique. Participants and their families, as well as postoperative outcome assessors, will remain blinded to treatment allocation whenever possible.

Intervention model description

Participants will be randomized in a 1:1 ratio to undergo transurethral Holmium:YAG laser cystolithotripsy using either a dusting strategy or a fragmentation strategy for pediatric bladder stones.

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Children aged less than 18 years. 2. Radiologically confirmed single bladder stone less than 3 cm. 3. Suitable for transurethral cystolithotripsy. 4. Fit for general anesthesia. 5. Written informed consent from parents or legal guardians.

Exclusion criteria

1. Giant bladder stones more than 3 cm. 2. Urethral pathology preventing safe transurethral access. 3. Major lower urinary tract anomaly or neurogenic bladder. 4. Active untreated urinary tract infection. 5. Coagulation disorder or contraindication to endoscopic surgery.

Design outcomes

Primary

MeasureTime frameDescription
Total Operative TimeDuring the index transurethral cystolithotripsy procedureTotal operative time will be measured in minutes from insertion of the endoscope into the urethra until completion of bladder stone clearance and termination of the procedure, including active fragment retrieval when required.

Secondary

MeasureTime frameDescription
Laser TimeDuring the index transurethral cystolithotripsy procedureLaser time will be measured in minutes as the cumulative duration of active Holmium:YAG laser firing during the index transurethral cystolithotripsy procedure.
Need for Active Fragment ExtractionDuring the index transurethral cystolithotripsy procedureThe need for active fragment extraction will be recorded as whether stone fragments required active removal using endoscopic retrieval maneuvers during the index transurethral cystolithotripsy procedure.
Endoscopic Stone-Free Status at the End of the ProcedureAt the end of the index transurethral cystolithotripsy procedEndoscopic stone-free status will be assessed at the end of the procedure and defined as no visible residual bladder stone fragments on final endoscopic inspection.
Postoperative HematuriaFrom the end of the procedure to 1 month postoperativelyPostoperative hematuria will be recorded based on clinical observation or patient/guardian report during postoperativ follow-up.

Countries

Egypt

Contacts

CONTACTHany F Badawy, MD
Hanyfathy86@gmail.com+201149525028
CONTACTGhada S Etman, MD
DrhanYFATHY86@GMAIL.COM+2010 07913852
PRINCIPAL_INVESTIGATORHany F Badawy, MD

Faculty of Medicine, Beni-Suef University hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026